Faculty profile

Jan Dutz

ResearcherDermatology and Skin ScienceUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Jan Dutz

Researcher

Dermatology and Skin Science

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 12 research grants (11 CIHR, 1 NSERC), most recently in 2024.
Supervised 3 trainees who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

161

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Regulatory T Cells Autoimmune Diabetes Cytotoxic T Cells Phototherapy Atopic Dermatitis Chronic Inflammation Epidemiology Eczema Dermatology

Latest papers

Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.
American journal of hematology · 2026
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis.
ACR open rheumatology · 2026

All 47 publications

Latest funding

Mapping the current landscape, treatment patterns, and access to health services for eczema patients in British Columbia
CIHR · 2024 · Principal investigator
$100,000
Investigating the pathogenic role of plasmacytoid dendritic cells and non-pDC immune cells in cutaneous lupus erythematosus
CIHR · 2023 · Supervisor
$6,000
Inbibition of tissue resident memory T-cells as a therapy for contact hypersensitivity
CIHR · 2022 · Nominated PI
$50,000

All 21 grants and awards

47 publications.

Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Leung E, Fragola NR, Sharp EW, Harrison RA, Peterson E, Varghese J, Jackson S, You XJ, VanderVeer E, Trinder M, Sutherland A, Dutz J, Kaniewski P, McClain KL, Abla O, Fajgenbaum DC, Chen LYC

American journal of hematology2026

DOI: 10.1002/ajh.70309 PMID: 41928050

Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.

Alpsoy E, Caproni M, Wetter DA, Goebeler M, Levell NJ, Schneider SW, Salavastru C, Llamas-Velasco M, Marzano AV, Akyol M, Dutz J, Jachiet M, Kawakami T, Mariotti EB, Maronese CA, Micheletti RG, Monfort JB, Piette W, Ratzinger G, Szepietowski JC, Werth VP, Sunderkötter C

Journal of the European Academy of Dermatology and Venereology : JEADV2026

DOI: 10.1111/jdv.70249 PMID: 41399325

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis.

Clark J, Chan D, Dhillon D, Dutz J, Goobie G, Huang K

ACR open rheumatology2026

DOI: 10.1002/acr2.90010 PMID: 41610110

Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance

Papp KA, Puig L, Beecker J, Chandran V, Claveau J, Cortés J, Dutz J, Hornick NI, Juergens RA, Melosky B

Journal of the European Academy of Dermatology and Venereology202513 citations

DOI: 10.1111/jdv.20809

Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients.

Beckett M, Tan J, Bonnardeaux E, Dutz J, Shojania K, To F, Obrzut A, Aviña-Zubieta J, Huang K

Rheumatology (Oxford, England)2024

DOI: 10.1093/rheumatology/kead404 PMID: 37584672

Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Gladman DD, Chandran V, Rosen CF, Rohekar S, Boyd T, Eder L, Rahman P, Dutz J, Chan J, Haydey RP, Barac S, Laliberté MC, Girard T, Fournier PA, Sutton M, Pereira D, Chim T, Coupal L, Choquette D

The Journal of rheumatology2024

DOI: 10.3899/jrheum.2023-0716 PMID: 38359937

Top 10 research priorities for basal cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative.

Shoimer I, Kleiner O, Manion R, Dutz J, Philip A, Chan AW, Skin Investigation Network of Canada Priority Setting Collaborative

The British journal of dermatology2024

DOI: 10.1093/bjd/ljad391 PMID: 38184850

Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma.

Bergeron A, Nessim C, Kleiner O, Manion R, Dutz J, Philip A, Chan AW, Skin Investigation Network of Canada Priority Setting Collaborative

The British journal of dermatology2024

DOI: 10.1093/bjd/ljad398 PMID: 37864824

Rosai-Dorfman-Destombes disease in adults: a single center experience.

Leung E, Pryma C, Murphy S, Harrison R, Peterson E, Tsang PWK, Varghese J, You XJ, Slack GW, Skinnider BF, Ng T, Young S, Burrell S, Stubbins R, Lim H, Carruthers M, Dutz J, Diamond EL, Chen LYC

Annals of hematology2024

DOI: 10.1007/s00277-024-06019-w PMID: 39331156

Treatment Outcomes of IgA Vasculitis in Adults: A Review.

Starkey SY, Akuffo-Addo E, Johnston L, Mar K, Kashetsky N, AlHalees Z, Dutz J, Mukovozov I

Journal of cutaneous medicine and surgery2024

DOI: 10.1177/12034754241269197 PMID: 39107929

Mapping the current landscape, treatment patterns, and access to health services for eczema patients in British Columbia

Principal investigatorCIHR2024Pro. Gr. - PA: Inst. of Musculoskeletal Health and Arthritis: IMHA Mandate Areas

Principal investigators: Kalia, Sunil; Avina-Zubieta, Juan A; Dutz, Jan P; Lacaille, Diane V; Lui, Harvey

Keywords: Atopic Dermatitis; Chronic Inflammation Epidemiology; Eczema

$100,000

Investigating the pathogenic role of plasmacytoid dendritic cells and non-pDC immune cells in cutaneous lupus erythematosus

SupervisorCIHR2023Canada Graduate Scholarships - Michael Smith Foreign Study Supplements

Principal investigators: Khosravi-Hafshejani, Touraj

Keywords: Cutaneous Lupus Erythematosus; Non-Pdc Immune Cells; Plasmacytoid Dendritic Cellsd; T-Cells

$6,000

Inbibition of tissue resident memory T-cells as a therapy for contact hypersensitivity

Nominated PICIHR2022Operating Grant: Canadian Dermatology Foundation - Innovation Grants

Principal investigators: Dutz, Jan P

Keywords: Dermatology; T-Cells

$50,000

Cutaneous adjuvant conditioning to enhance vaccine responses

Nominated PICIHR2021Project Grant - PA: Pandemic and Health Emergencies Research

Principal investigators: Dutz, Jan P

Keywords: Skin Immune System; Tissue Resident Memory T Cells; Tlr9; Vaccine Adjuvant

$450,000

Phototherapy to modulate regulatory T cells and prevent autoimmune disease

Nominated PICIHR2020Project Grant

Principal investigators: Dutz, Jan P

Keywords: Autoimmune Diabetes; Cytotoxic T Cells; Phototherapy; Regulatory T Cells

$382,499

Phototherapy to modulate regulatory T cells and prevent autoimmune disease

Nominated PICIHR2019Project Grant - PA: Nutrition, Metabolism and Diabetes

Principal investigators: Dutz, Jan P

Keywords: Autoimmune Diabetes; Cytotoxic T Cells; Phototherapy; Regulatory T Cells

$100,000

Canadian Autoimmunity Standardization Core (CAN-ASC)

Co-investigatorCIHR2018Team Grant: Human Immunology Initiative: Standardization Core

Principal investigators: Levings, Megan K

Keywords: Autoimmunity; Biomarkers; Clinical Immunology; Flow Cytometry; Genomics; Human Immunology; Metabolomics; Microbiome; Proteomics

$1,500,000

Canadian Autoimmunity Standardization Core (CAN-ASC)

Co-investigatorCIHR2017Team Grant: Human Immunology Initiative: Standardization Core - LOI

Principal investigators: Levings, Megan K

Keywords: Autoimmunity; Clinical Immunology; Flow Cytometry; Genomics; Human Immunology; Metabolomics; Microbiome; Proteomics

$25,000

Role of CLEC12B+ macrophages in the pathogenesis of vitiligo and melanoma

Co-investigatorCIHR2017Project Grant

Principal investigators: Zhou, Youwen

Keywords: Gene Knockout; Gene Silensing; Growth Factors; Innate Immunity; Macrophages; Melanocytes; Melanoma; Microenvironment; Monoclonal Antibodies; Vitiligo

$745,875

Flow Cytometer for Radioactive Samples

Co-investigatorNSERC2015Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Hafeli, Urs

$150,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Regulatory T Cells Dear Professor Dutz, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Mapping the current landscape, treatment patterns, and access to health services for eczema patients in British Columbia" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Jan Dutz

Research

Latest papers

Latest funding

Lenalidomide-Dexamethasone as an Effective and&#xa0;Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and&#xa0;Pharmacophenomic Study.

Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis.

Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance

Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients.

Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Top 10 research priorities for basal cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative.

Skin Investigation Network of Canada (SkIN&#xa0;Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma.

Rosai-Dorfman-Destombes disease in adults: a single center experience.

Treatment Outcomes of IgA Vasculitis in Adults: A Review.

Flow Cytometer for Radioactive Samples

Frequent collaborators

Stephanie Keeling

Jan Dutz

Vinod Chandran

Proton Rahman

Anie Philip

Rachael Manion

Janet Pope

An-Wen Chan

Robert Gniadecki

Anie Philip

Lihi Eder

Proton Rahman

Ronald Vender

Vincent Piguet

Elena Netchiporouk

Jacob Karsh

Morris Manolson

Stephen Betschel

Youwen Zhou

Boris Stoeber

Lucie Germain

Rosalyn Juergens

Susan Waserman

Mohannad Abu Hilal

Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma.